PHA-30021 - The Pharmaceutical Industry at the Cutting Edge
Coordinator: David Morgan Tel: +44 1782 7 33474
Lecture Time: See Timetable...
Level: Level 6
Credits: 30
Study Hours: 300
School Office:

Programme/Approved Electives for 2022/23

None

Available as a Free Standing Elective

No

Co-requisites

None

Prerequisites

None

Barred Combinations

None

Description for 2022/23

The global pharmaceutical industry has experienced substantial change in recent years. In order to stay abreast of current developments graduates must have a high-level awareness of both the science and the business of the global pharmaceutical industry. They must understand not only the teams they will be a member of but also understand the holistic nature of the global business and how different teams work together synergistically within the relevant frameworks. The global pharmaceutical research scientist and industry pharmaceutical business professional are, today, going to be more involved in the evaluation of scientific data and the business case involved in new science acquisition. Graduates must leave with a significant awareness of how to operate in this environment and understand the contribution of each function, within the industry, to bringing a new molecule from research to the market. This module will continue the delivery of management training and provide significant detail and awareness of the Strategic Partnering and Business Development skills essential for this environment.
Complex synergistic relationships within the global pharmaceutical industry will be placed within the context of product development and the product life cycle, including post-marketing pharmacovigilance. Pharmaceutical manufacture will be emphasised in the context of outsourcing and global / local sourcing and supply chain strategies. Principles and practicalities of product marketing will be discussed in the context of appropriate global codes of conduct. This includes discussions of financial models and extensions, such as divestment, spin-offs and franchising. Underpinning this will be the concepts and practices securing global patents and protection of intellectual property.
Sitting in the final year of the programme, this module will develop the management and leadership skills of students and how they will interact with, negotiate with and influence their peers and partners. This includes the principles of media interaction and its application to successful product development and marketing.
The module will be delivered by experts with significant experience across the breadth of the pharmaceutical industry, thus ensuring that the graduates leave not just with an excellent scientific portfolio of knowledge and experience, but also with an awareness of where they fit within the multi-disciplinary teams that they will be a part of when they join the industry. Input from external stakeholders will ensure that the module, and the programme, is relevant and fully up to date both in its scientific and business content.


Aims
This module aims to develop students¿ knowledge of the complex synergistic relationships within the global pharmaceutical industry of the 21st century by placing their studies in the context of product development and the product life cycle, including post-marketing pharmacovigilance. Pharmaceutical manufacture will be emphasised in the context of outsourcing and global / local sourcing and supply chain strategies. Principles and practicalities of product marketing will be discussed in the context of appropriate global codes of conduct. This includes discussions of financial models and extensions, such as divestment, spin-offs and franchising. Underpinning this, as seen across all three Levels of the Pharmaceutical Science, Technology and Business BSc programme, will be the concepts and practices securing global patents and protection of intellectual property. This module will also seek to develop the management and leadership skills of students and how they will interact with, negotiate with and influence their peers and partners. This includes the principles of media interaction and its application to successful product development and marketing.

Talis Aspire Reading List
Any reading lists will be provided by the start of the course.
http://lists.lib.keele.ac.uk/modules/pha-30021/lists

Intended Learning Outcomes

understand systematically and critically appraise the clinical development of pharmaceutical products in the context of global (and hence, harmonisation) marketing, life-cycle management, post-market surveillance and in planning for future products / product extensions: 1,2,3
demonstrate an in-depth understanding of global pharmaceutical manufacturing in the context of the total global supply chain, including global and local sourcing strategies, supply operations, outsourcing and supply agreements: 1,2,3
demonstrate a systematic understanding and apply knowledge of leading edge topics in global product commercialisation with regard to its principles, limitations, key marketing and promotion principles, (legal and regulatory) codes of conduct and product termination, underpinned by a knowledge and understanding of the application of global patents and protection of intellectual property: 1,2,3
demonstrate a systematic understanding and apply the principles of management training in facilitating successful pharmaceutical product development: 1,2,3
demonstrate a systematic knowledge of concepts from the forefront of the arena of global pharmaceutical product development, from the key underpinning science to the applied and regulatory context: 1,2,3
synthesise, evaluate and contextualise the key scientific, legal and business information to generate business proposals and product submission dossiers: 1,2,3
demonstrate a systematic understanding of and practice the concepts of working within the complex team-based and inter-disciplinary global pharmaceutical industry: 1,2,3
demonstrate an in-depth understanding of the principles of leadership within management teams and practise the application of these concepts within the complex team-based and inter-disciplinary global pharmaceutical industry: 1,2,3
communicate complex concepts effectively, both orally and in writing, in a manner that reflects professional work: 1,2,3

Study hours

Lectures/tutorials: 30 hours
Workshops: 30 hours
Directed private study and assessment: 240 hours

School Rules

None

Description of Module Assessment

1: Presentation weighted 30%
Current topics in the pharmaceutical industry oral presentation
Students will present a business case or project management plan on an assigned topic relevant to current topics/issues face by the pharmaceutical industry. This is in individual presentation and will last no more than 10 minutes followed by a 5 minute Q&A.

2: Group Project weighted 30%
Task-based group project
A group project report of no more than 3000 words on topics/methods that are relevant to the pharmaceutical industry. A group mark will be awarded for this assessment component.

3: Oral Presentation weighted 40%
Oral presentation on selected research area
Students will present an oral presentation of their analysis/research findings on a current topic/issue relevant to the pharmaceutical industry to their peer group and examiners (15 minute presentation + 5 minute Q&A). The research topic will be proposed by the student and agreed with the examiners prior to the assessment.